Clinical Trial Update: Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial [Phase 4]

View source ↗

Summary

This clinical trial update reports the results of a Phase 4 randomized study comparing ruxolitinib monotherapy to its combination with tacrolimus and corticoste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Corticosteroids (corticosteroids)
• Ruxolitinib (ruxolitinib)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Vitiligo | Phase 4 | Status: COMPLETED